英文名稱 Anti-BCMA/CD269

中文名稱 B淋巴細(xì)胞成熟因子抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來源 Rabbit

克隆類型 polyclonal

交叉反應(yīng) Human, Mouse, Rat

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 細(xì)胞生物 免疫學(xué) 轉(zhuǎn)錄調(diào)節(jié)因子 b-淋巴細(xì)胞

蛋白分子量 predicted molecular weight: 20kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanBCMA C-terminus

亞 型 IgG

純化方法 affinity purified by Protein A

儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodiumazide

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500IHC-F=1:100-500 Flow-Cyt=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件 Store at -20 °C for oneyear.

別 名 B cell maturation antigen; B Cell Maturation Factor;B cell maturation protein; BCM; BCMA; CD269; CD269 antigen; TNFRSF17; TumorNecrosis Factor Receptor Member 17; Tumor necrosis factor receptor superfamilymember 17; TNR17_HUMAN.